Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Relx PLC Director's Dealing 2014

Mar 5, 2014

5248_dirs_2014-03-05_d55a2d6e-5f54-4847-a256-e612e3271b9c.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 5311B

Reed Elsevier PLC

04 March 2014

ISSUED ON BEHALF OF REED ELSEVIER PLC AND REED ELSEVIER NV

4 March 2014

Director/PDMR Shareholdings

Reed Elsevier announces that it today received notification of the following transactions in the securities of Reed Elsevier by Erik Engstrom, Director, and Ian Fraser and Henry Udow, PDMRs:

(a) Reed Elsevier Group plc Bonus Investment Plan 2010 ("BIP")

Vesting of matching shares

In connection with the vesting on 28 February 2014 of the share awards granted in May 2011 under BIP, the table below shows the total numbers of shares which vested and the numbers of shares actually released to Erik Engstrom, Ian Fraser and Henry Udow after taking account of shares withheld to meet personal tax and national insurance obligations.

No. of Reed Elsevier PLC ordinary shares/ADRs* vested No. of Reed Elsevier NV ordinary shares/ADRs* vested No. of Reed Elsevier PLC ordinary shares/ADRs* released No. of Reed Elsevier NV ordinary shares/ADRs* released
Director
Erik Engstrom 55,364* 29,342*
PDMR
Ian Fraser 8,097 39,346 4,291 20,853
Henry Udow 37,758 20,011
9,224* 4,888*

*Denotes vesting/release of ADRs.  Each Reed Elsevier NV ADR represents 2 Reed Elsevier NV ordinary shares. Each Reed Elsevier PLC ADR represents 4 Reed Elsevier PLC ordinary shares.

The closing market price of each security on the date of vesting was £9.155 per Reed Elsevier PLC ordinary share, €15.88 per Reed Elsevier NV ordinary share, $61.48 per Reed Elsevier PLC ADR and $43.67 per Reed Elsevier NV ADR.

(b) Reed Elsevier Group plc Long Term Incentive Plan ("LTIP")

Vesting of performance shares

In connection with the vesting on 28 February 2014 of the share awards granted in May 2011 under LTIP, the table below shows the total numbers of shares which vested and the numbers of shares actually released to Ian Fraser and Henry Udow after taking account of shares withheld to meet personal tax and national insurance obligations.

No. of Reed Elsevier PLC ordinary shares vested No. of Reed Elsevier NV ordinary shares vested No. of Reed Elsevier PLC ordinary shares released No. of Reed Elsevier NV ordinary shares released
PDMR
Ian Fraser 49,214 32,876 26,083 17,424
Henry Udow 47,209 31,536 25,020 16,714

The closing market price of each security on the date of vesting was £9.155 per Reed Elsevier PLC ordinary share and €15.88 per Reed Elsevier NV ordinary share.

(c) Reed Elsevier Group plc Executive Share Option Scheme ("ESOS"): Exercise of Options

The following options to acquire Reed Elsevier ordinary shares were exercised by Erik Engstrom on 4 March 2014.

Date of grant Plan name No. of Reed Elsevier PLC ordinary shares No. of Reed Elsevier NV ordinary shares Option price per share
Director
Erik Engstrom 13 March 2006 ESOS 178,895 £5.305
13 March 2006 ESOS 120,198 €11.470

(d) Sale of shares

On 4 March 2014, Erik Engstrom and Ian Fraser sold the following securities set out below.

No. of Reed Elsevier PLC ordinary shares/ADRs* sold Price per Reed Elsevier PLC ordinary shares/ADRs** No. of Reed Elsevier NV ordinary shares/ADRs* sold Price per Reed Elsevier NV ordinary shares/ADRs**
Director
Erik Engstrom 174,895 £9.138158 119,198 €15.7552
28,342* $43.3972**
PDMR
Ian Fraser 26,083 £9.05 38,277 €15.64

*Denotes sale of ADRs.  Each Reed Elsevier NV ADR represents 2 Reed Elsevier NV ordinary shares.

** Denotes price per ADR

Following these transactions, the current interests of Erik Engstrom in the share capital of Reed Elsevier PLC and Reed Elsevier NV are:

Reed Elsevier PLC         118,552 ordinary shares

Reed Elsevier NV           516,765 ordinary shares

- ENDS -

Enquiries

Paul Abrahams (Media)                                     

+44 20 7166 5724                                             

Colin Tennant (Investors)

+44 20 7166 5751

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSSSFFULFLSELD